Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90

Angela M. Feraco, Yiwang Zhou, Ying Zheng, Lianna J. Marks, Alison Friedmann, Howard J. Weinstein, Michael P. Link, Jamie E. Flerlage

Blood Adv (2023) 7 (21): 6665–6667.

https://doi.org/10.1182/bloodadvances.2023010944

Published: 2023